KORRO BIO Trademark

Trademark Overview


On Thursday, July 7, 2022, a trademark application was filed for KORRO BIO with the United States Patent and Trademark Office. The USPTO has given the KORRO BIO trademark a serial number of 97978738. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Thursday, August 22, 2024. This trademark is owned by Korro Bio, Inc.. The KORRO BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development; Research and development of pharmaceutical products; Research and development in the field of bioscience; Research and development of biomedical compounds comprised of nucleotide polymers for use in targeted pharmaceutical therapies for the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders; Research and development of pharmaceutical preparations for the treatment of liver-based disorders, eye disorders and CNS disorders; Research and development of biomedical compounds comprised of nucleotide polymers for targeted RNA editing; Research and development of oligonucleotide drug platforms for use in the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and...
korro bio

General Information


Serial Number97978738
Word MarkKORRO BIO
Filing DateThursday, July 7, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateThursday, August 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements


NOT AVAILABLE"BIO"
Goods and ServicesPharmaceutical research and development; Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development; Research and development of pharmaceutical products; Research and development in the field of bioscience; Research and development of biomedical compounds comprised of nucleotide polymers for use in targeted pharmaceutical therapies for the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders; Research and development of pharmaceutical preparations for the treatment of liver-based disorders, eye disorders and CNS disorders; Research and development of biomedical compounds comprised of nucleotide polymers for targeted RNA editing; Research and development of oligonucleotide drug platforms for use in the treatment of various conditions, diseases and disorders, including rare diseases, genetic disorders, liver diseases, eye diseases, and CNS disorders

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 26, 2022
Primary Code042
First Use Anywhere DateThursday, September 10, 2020
First Use In Commerce DateThursday, September 10, 2020

Trademark Owner History


Party NameKorro Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameKorro Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Thursday, May 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 11, 2022NEW APPLICATION ENTERED
Thursday, April 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 20, 2023ASSIGNED TO EXAMINER
Tuesday, May 9, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, May 15, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, May 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 31, 2023NON-FINAL ACTION WRITTEN
Wednesday, May 31, 2023NON-FINAL ACTION E-MAILED
Wednesday, May 31, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 28, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, August 28, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, September 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 29, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 11, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 11, 2024SOU EXTENSION 1 GRANTED
Tuesday, June 11, 2024SOU EXTENSION 1 FILED
Thursday, June 13, 2024USE AMENDMENT FILED
Tuesday, June 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024TEAS STATEMENT OF USE RECEIVED
Friday, August 2, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 8, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, August 20, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 13, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, August 20, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, August 22, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, August 22, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 22, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED